中华外科杂志2024年7月第62卷第7期ChinJSurg,July2024,Vol.62,No.7·659·2024版NCCN指南中胰腺癌外科治疗部分解读马明剑程合陈榆升刘辰虞先濬复旦大学附属肿瘤医院胰腺外科复旦大学上海医学院肿瘤学系上海市胰腺肿瘤研究所复旦大学胰腺肿瘤研究所,上海200032通信作者:虞先濬,Email:yuxianjun@fudanpci.org【摘要】胰腺癌是消化系统恶性程度较高的肿瘤,根治性手术是目前唯一可能治愈胰腺癌的手段。近十年来,胰腺外科发展迅速,各类新技术、新理念不断涌现,其中以微创技术的运用和新辅助治疗理念的普及最为引人注目;同时,胰腺癌的外科治疗仍有很长的道路要走,许多问题亟待解决。本文对2024版NCCN指南中胰腺癌外科治疗部分进行介绍,重点解读微创入路和开腹手术治疗、扩大淋巴结清扫、联合血管切除重建、胰颈癌的手术治疗和新辅助治疗这几方面,同时对其中尚未解决的问题做简要讨论。【关键词】胰腺肿瘤;外科手术;微创入路手术;新辅助治疗基金项目:国家自然科学基金(82072693、81902417、82172884)Interpretationofthesurgicaltreatmentofpancreaticcancerofthe2024editionoftheNCCNguidelinesMaMingjian,ChengHe,ChenYusheng,LiuChen,YuXianjunDepartmentofPancreaticSurgery,FudanUniversityShanghaiCancerCenter,DepartmentofOncology,ShanghaiMedicalCollege,FudanUniversity,ShanghaiPancreaticCancerInstitute,PancreaticCancerInstitute,FudanUniversity,Shanghai200032,ChinaCorrespondingauthor:YuXianjun,Email:yuxianjun@fudanpci.org【Abstract】Pancreaticcancerisahighlymalignanttumorinthedigestivesystem,andradicalsurgeryistheonlypossiblemeanstocurepancreaticcanceratpresent.Inthepastdecade,pancreaticsurgeryhasbeendevelopingrapidly,withvariousnewtechnologiesandconceptsemerging,amongwhichtheuseofminimallyinvasivetechniquesandthepopularizationofneoadjuvanttherapyconceptsarethemostnotable.Atthesametime,thesurgicaltreatmentofpancreaticcancerstillhasalongwaytogo,andmanyproblemsneedtobesolvedurgently.Thisarticleintroducesthesurgicaltreatmentofpancreaticcancerinthe2024editionoftheNCCNguidelines,focusingonminimallyinvasiveandopensurgicaltreatments,expandedlymphnodedissection,combinedvascularresectionandreconstruction,surgicaltreatmentofpancreaticneckcancerandne...